Every 22 seconds, someone in India is diagnosed with cancer. Over the past half-century, medical science has mapped the human genome, eradicated smallpox, and turned HIV into a manageable chronic illness. Yet despite more than 50 years of relentless research following the launch of the “War on Cancer,” a single, universal cure remains elusive.
This lucid explainer video tackles the core reasons behind this challenge, revealing why defeating cancer is as much an infrastructural battle as it is a biological one.
The Biological Paradox: Fighting Ourselves
Unlike infectious diseases caused by foreign bacteria or viruses, cancer begins from within our own bodies. A mutated cell breaks the normal rules of cellular division, evades the immune system, and refuses to die. The clinical dilemma is profound: How do you kill the diseased cell without destroying the healthy person carrying it?
Furthermore, “cancer” is not a single disease—it encompasses hundreds of distinct conditions. Even within the same organ, tumours behave radically differently. For example, in India, roughly one in four breast cancer patients has triple-negative breast cancer, which lacks oestrogen, progesterone, and HER2 receptors and therefore fails to respond to common hormone or targeted therapies. Compounding this is cellular evolution: as therapy shrinks a tumour, a resistant sub-population can survive, mutate, multiply, and render initial treatments obsolete. When cancer cells metastasize to distant organs, treatment shifts from definitive elimination to disease control.
The Indian Reality: The Barrier of Time and Distance
In India, biological complexity is magnified by socio-geographic hurdles. The Indian Council of Medical Research (ICMR) estimates that 1 in 9 Indians will develop cancer by age 74. Yet access to care remains unequal:
- Geographic Strain: A study in South India showed rural cancer patients travel a median of 110 km repeatedly for care, compared to 45 km for urban residents.
- Infrastructural Deficits: While 58% of Indian cancer patients would benefit from radiotherapy, only 28.5% receive it.
- Dangerous Delays: Nearly 30% of patients experience a lag of over a month between diagnosis and starting treatment.
Science answers whether a drug works; only an equitable health system determines if a patient receives it in time.
Redefining the Victory
India is actively countering these hurdles through systemic innovations. The National Cancer Grid connects more than 380 centres treating over 8.6 lakh new patients annually. Ayushman Bharat (PM-JAY) provides critical financial risk protection, while homegrown breakthroughs like NexCAR19—India’s first indigenous CAR-T cell therapy—offer cutting-edge immunotherapy at roughly one-tenth of international costs.
Ultimately, winning against cancer will rarely look like a single morning announcement of a “cure”. Real victory lies in early detection, targeted precision therapy, and primary prevention: eliminating tobacco (linked to 1 in 4 Indian cancers) and scaling HPV vaccination to eradicate cervical cancer. The greatest cures may simply be the cancers that never happen.
Watch the complete breakdown in the embedded video.